Clinical Trial Update: Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing 61.2 Gy versus 50.4 Gy radiotherapy dose for locally advanced esophageal carcinoma (esophageal squamous cell carcinoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 3 | Status: UNKNOWN